Amanote Research
Register
Sign In
Neutrophil–lymphocyte Ratio Predicts Response to Chemotherapy in Triple-Negative Breast Cancer
Current Oncology
- Canada
doi 10.3747/co.25.3888
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
April 30, 2018
Authors
S. Chae
K.M. Kang
H.J. Kim
E. Kang
S.Y. Park
J.H. Kim
S.H. Kim
S.W. Kim
E.K. Kim
Publisher
MultiMed Inc.
Related search
Neutrophil/Lymphocyte Ratio Predicts Chemotherapy Outcomes in Patients With Advanced Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Prognostic Role for Derived Neutrophil-To-Lymphocyte Ratio in Early Breast Cancer
Annals of Oncology
Medicine
Oncology
Hematology
Prognostic Role and Clinical Association of Tumor-Infiltrating Lymphocyte, Programmed Death Ligand-1 Expression With Neutrophil-Lymphocyte Ratio in Locally Advanced Triple-Negative Breast Cancer
Cancer Research and Treatment
Cancer Research
Oncology
DNA Methyltransferase Expression in Triple-Negative Breast Cancer Predicts Sensitivity to Decitabine
Journal of Clinical Investigation
Medicine
High Preoperative Neutrophil-Lymphocyte Ratio Predicts Poor Survival in Patients With Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
The Prognostic Impact of Neutrophil-To-Lymphocyte Ratio, Lymphocyte-To-Monocyte Ratio, and Platelet-To-Lymphocyte Ratio in Patients With Advanced Colorectal Cancer Treated With First-Line Chemotherapy
Przeglad Gastroenterologiczny
Gastroenterology
Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio, and Risk of Thromboembolism in Patients With Lymphoma Receiving Chemotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Dasatinib Sensitises Triple Negative Breast Cancer Cells to Chemotherapy by Targeting Breast Cancer Stem Cells
British Journal of Cancer
Cancer Research
Oncology
Thymosin Beta 15A (TMSB15A) Is a Predictor of Chemotherapy Response in Triple-Negative Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
